Radnet (RDNT) closed at $69.71 on November 20, 2026, up 0.3% from the previous close, on volume of 568,920 shares (30-day average 641,065).
Data as of November 20, 2026.
20-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Nov 5, 2026 | Put Spread | 18-Dec-2660 : 75 P | 818 |
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 20, 2026. See the largest for 5, 30, 60 and 90 days
Globe Newswire (Thu, 19-Nov 6:00 AM ET)
Analysts Offer Insights on Healthcare Companies: Radnet (RDNT) and Roche Holding AG (OtherRHHVF)
TipRanks (Tue, 17-Nov 3:10 AM ET)
Globe Newswire (Sun, 8-Nov 4:01 PM ET)
RadNet, Inc. Announces Date of its Third Quarter 2026 Financial Results Conference Call
Globe Newswire (Thu, 29-Oct 6:00 AM ET)
RadNet, Inc. Announces Agreement to Acquire ONRAD, Inc.
Globe Newswire (Mon, 26-Oct 4:01 PM ET)
New Study Shows DeepHealth AI Could Help Avoid Nearly One in Five Prostate Biopsies
Globe Newswire (Thu, 8-Oct 6:00 AM ET)
Globe Newswire (Thu, 1-Oct 6:00 AM ET)
Globe Newswire (Wed, 9-Sep 6:00 AM ET)
RadNet to Host Free Prostate Cancer Webinar on September 19, 2026
Globe Newswire (Wed, 9-Sep 6:00 AM ET)
Globe Newswire (Tue, 8-Sep 6:00 AM ET)
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostic.
Radnet trades on the NASDAQ stock market under the symbol RDNT.
As of November 20, 2026, RDNT stock price climbed to $69.71 with 568,920 million shares trading.
RDNT has a beta of 0.90, meaning it tends to be less sensitive to market movements. RDNT has a correlation of 0.11 to the broad based SPY ETF.
RDNT has a market cap of $5.49 billion. This is considered a Mid Cap stock.
Last quarter Radnet reported $638 million in Revenue and $.30 earnings per share. This fell short of revenue expectation by $-620,736 and exceeded earnings estimates by $.08.
In the last 3 years, RDNT traded as high as $93.65 and as low as $31.55.
The top ETF exchange traded funds that RDNT belongs to (by Net Assets): IJR, VTI, IWM, VB, QTUM.
RDNT has underperformed the market in the last year with a price return of -12.0% while the SPY ETF gained +6.9%. RDNT has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -9.5% and -8.3%, respectively, while the SPY returned -9.3% and -6.2%, respectively.
RDNT support price is $67.38 and resistance is $71.64 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RDNT shares will trade within this expected range on the day.